1. Home
  2. RPTX vs CRT Comparison

RPTX vs CRT Comparison

Compare RPTX & CRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPTX
  • CRT
  • Stock Information
  • Founded
  • RPTX 2016
  • CRT 1991
  • Country
  • RPTX Canada
  • CRT United States
  • Employees
  • RPTX N/A
  • CRT N/A
  • Industry
  • RPTX Biotechnology: Pharmaceutical Preparations
  • CRT Oil & Gas Production
  • Sector
  • RPTX Health Care
  • CRT Energy
  • Exchange
  • RPTX Nasdaq
  • CRT Nasdaq
  • Market Cap
  • RPTX 53.2M
  • CRT 64.0M
  • IPO Year
  • RPTX 2020
  • CRT 1992
  • Fundamental
  • Price
  • RPTX $1.12
  • CRT $10.75
  • Analyst Decision
  • RPTX Strong Buy
  • CRT
  • Analyst Count
  • RPTX 3
  • CRT 0
  • Target Price
  • RPTX $4.50
  • CRT N/A
  • AVG Volume (30 Days)
  • RPTX 185.4K
  • CRT 25.8K
  • Earning Date
  • RPTX 03-03-2025
  • CRT 01-01-0001
  • Dividend Yield
  • RPTX N/A
  • CRT 7.93%
  • EPS Growth
  • RPTX N/A
  • CRT N/A
  • EPS
  • RPTX N/A
  • CRT 1.13
  • Revenue
  • RPTX $53,477,000.00
  • CRT $7,711,133.00
  • Revenue This Year
  • RPTX N/A
  • CRT N/A
  • Revenue Next Year
  • RPTX $7.11
  • CRT N/A
  • P/E Ratio
  • RPTX N/A
  • CRT $9.35
  • Revenue Growth
  • RPTX 4.58
  • CRT N/A
  • 52 Week Low
  • RPTX $1.06
  • CRT $8.88
  • 52 Week High
  • RPTX $5.66
  • CRT $17.30
  • Technical
  • Relative Strength Index (RSI)
  • RPTX 36.62
  • CRT 52.09
  • Support Level
  • RPTX $1.12
  • CRT $10.38
  • Resistance Level
  • RPTX $1.25
  • CRT $10.83
  • Average True Range (ATR)
  • RPTX 0.09
  • CRT 0.24
  • MACD
  • RPTX -0.00
  • CRT -0.02
  • Stochastic Oscillator
  • RPTX 22.64
  • CRT 56.06

About RPTX Repare Therapeutics Inc.

Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.

About CRT Cross Timbers Royalty Trust

Cross Timbers Royalty Trust is a United States based trust. Its principal asset is the net profits interests. The net profits interests are derived from producing royalty, overriding royalty interests, and working interests properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.

Share on Social Networks: